Genesis Financial Group LLC Takes Position in Astera Labs, Inc. $ALAB

Genesis Financial Group LLC bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 10,900 shares of the company’s stock, valued at approximately $1,813,000. Astera Labs comprises 1.1% of Genesis Financial Group LLC’s portfolio, making the stock its 28th biggest position.

Several other large investors have also recently bought and sold shares of ALAB. Clearstead Advisors LLC grew its stake in Astera Labs by 13.6% in the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock valued at $125,000 after purchasing an additional 76 shares in the last quarter. Great Valley Advisor Group Inc. raised its stake in shares of Astera Labs by 2.2% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after purchasing an additional 90 shares in the last quarter. Rye Brook Capital LLC raised its stake in shares of Astera Labs by 1.1% during the 3rd quarter. Rye Brook Capital LLC now owns 9,200 shares of the company’s stock worth $1,801,000 after purchasing an additional 100 shares in the last quarter. Hilltop National Bank boosted its holdings in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares during the last quarter. Finally, Assetmark Inc. boosted its holdings in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

ALAB has been the topic of a number of recent analyst reports. Citigroup started coverage on shares of Astera Labs in a report on Thursday. They set a “buy” rating and a $200.00 target price on the stock. Northland Securities increased their price target on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research note on Tuesday, December 9th. Barclays set a $165.00 price objective on shares of Astera Labs in a research report on Thursday, January 15th. Royal Bank Of Canada initiated coverage on shares of Astera Labs in a research note on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price objective on the stock. Finally, Loop Capital initiated coverage on shares of Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price for the company. Fifteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $199.44.

Astera Labs Trading Up 10.2%

ALAB opened at $117.14 on Friday. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90. The stock’s fifty day simple moving average is $132.61 and its 200 day simple moving average is $160.43. The stock has a market cap of $20.06 billion, a PE ratio of 96.02, a price-to-earnings-growth ratio of 2.09 and a beta of 1.78.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. During the same period in the previous year, the business posted $0.37 earnings per share. The company’s revenue for the quarter was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Activity at Astera Labs

In related news, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $117.47, for a total transaction of $1,174,700.00. Following the completion of the sale, the general counsel owned 128,084 shares of the company’s stock, valued at approximately $15,046,027.48. The trade was a 7.24% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Jack R. Lazar sold 2,500 shares of the company’s stock in a transaction dated Monday, March 16th. The shares were sold at an average price of $130.00, for a total transaction of $325,000.00. Following the completion of the transaction, the director owned 84,851 shares in the company, valued at approximately $11,030,630. This trade represents a 2.86% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 384,292 shares of company stock worth $48,724,919 in the last quarter. 12.50% of the stock is owned by corporate insiders.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.